Modulation of cutaneous SP receptors in atopic dermatitis after UVA irradiation

Acta Dermato-Venereologica

Volumn 78, Issue 2, 1998, Pages 92-94

  Staniek, V ^a   Liebich, C ^b   Vocks, E ^b   Odia, S G ^b   Doutremepuich, J D ^c   Ring, J ^b   Claudy, A ^a   Schmitt, D ^a   Misery, L ^a,d  

^a INSERM   (France)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Galderma R and D   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Neuropeptides; Photobiology; Phototherapy; Substance P

Indexed keywords

SUBSTANCE P; SUBSTANCE P RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; BLOOD VESSEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; KERATINOCYTE; MODULATION; PRIORITY JOURNAL; SKIN INFLAMMATION; SKIN RECEPTOR; ULTRAVIOLET A RADIATION;

DERMATITIS, ATOPIC; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; RECEPTORS, NEUROKININ-1; SUBSTANCE P; ULTRAVIOLET THERAPY;

EID: 0031955489     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155598433386     Document Type: Article

References (17)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128 137.
2. Ring J. Atopy: condition, disease, or syndrome? In: Ruzicka T, Ring J, Przybilla B, eds. Handbook of Atopic Eczema, Berlin: Springer-Verlag, 3-8: 1991.
3. Lotti T, Hautmann G, Panconesi E. Neuropeptides in skin. J Am Acad Dermatol 1995; 33: 482-496.
4. Panconesi E, Hautmann G, Lotti T. Neuropeptides and skin: the slate of the art. J Eur Acad Dermatol Venereol 1994; 3: 109-115.
5. Tobin D, Nabarro G, Baart de le Faille H, van Vloten WA, van der Putte S, Schuurman HJ. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992; 90: 613-622.
6. Fantini F, Pincelli C, Romualdi P, Donatini A, Giannetti A. Substance P levels are decreased in lesional skin of atopic dermatitis. Exp Dermatol 1992; 1: 126-128.
7. Gianetti A, Girolomoni G, Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 1989; 121: 681-688.
8. Arenberger P, Leder RO, Abraham A, Chang JK, Farber EM. Substance P binding in normal neonatal foreskin. Br J Dermatol 1995; 132: 54-58.
9. Staniek V, Misery L, Doutremepuich JD, Claudy A, Schmitt D. Expression of substance P-receptors in normal skin and psoriasis. J Invest Dermatol 1997; 109: 456.
10. Al'Abadie M, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptides and neuronal marker in atopic dermatitis: a quantified immunohistochemical study. Eur J Dermatol 1994; 4: 394-398.
11. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Gianetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990; 122: 745-750.
12. Cappugi P, Tsampau D, Lotti T. Substance P provokes cutaneous erythema and edema through a histamine-independent pathway. Int J Dermatol 1992; 31: 206-209.
13. Greeno EW, Mantyh P, Vercellotti GM, Moldow CF. Functional neurokinin 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 1993; 177: 1269-1276.
14. Ansel JC, Brown JR,Payan DG,Brown MA. Substance P activates TNF-α gene expression in murine mast cells. J Immunol 1993; 150: 4478-4485.
15. Walsh LJ, Trinchieri G, Waldorf HA, Whitaker D, Murphy GF. Human dermal mast cells contain and release tumor necrosis factor α which induces endothelial leukocyte adhesion molecule Proc Natl Acad Sci USA 1991; 88: 4220-4225.
16. Matis WL, Lavker RM, Murphy F. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990; 94: 492-495.
17. Eschenfelder CC, Benrath J, Zimmermann M, Gillardon F. Involvement of substance P in ultraviolet irradiation-induced inflammation in rat skin. Eur J Neuroscience 1995; 7: 1520-1526.